Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salomão Zoppi is a premier diagnostic medicine company based in São Paulo, Brazil, recognized for its excellence in clinical pathology, medical imaging, and specialized women's health services. Founded in 1981 by Dr. Luís Salomão and Dr. Paulo Zoppi, the organization has grown into a significant player in the Brazilian healthcare market, known for its high technical standards and personalized patient care. In 2017, the company was acquired by DASA (Diagnósticos da América S.A.), the largest diagnostic medicine provider in Latin America, for approximately R$ 600 million. Operating as a premium brand within the DASA ecosystem, Salomão Zoppi offers a comprehensive suite of diagnostic solutions, including advanced genomic testing, oncology diagnostics, and fetal medicine. The company maintains a strong presence in the Greater São Paulo region with numerous high-tech units and a dedicated clinical staff.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salomao.